Diagnosis & Disease Information

FDA Approves Renal Replacement Solution

FDA Approves Phoxillum Renal Replacement Solution

The FDA has approved Phoxillum replacement solution for use during continuous renal replacement therapy (CRRT). Phoxillum can replace plasma volume removed by ultrafiltration and correct electrolyte and acid-base imbalances. The solution also may be used in cases of drug poisoning when CRRT is selected to remove dialyzable substances. Prescription Phoxillum is approved for both pediatric…

Clinical Decision Tool Helps Cut RRT Referral Time

PARIS—Primary care physicians who use a clinical decision support system (CDSS) may be able to avoid late referrals for renal replacement therapy (RRT), researchers reported at the 49th Congress of the European Renal Association-European Dialysis and Transplant Association.

Next post in Kidney Week 2011 General News